Clinical outcome of patients with refractory Kawasaki disease based on treatment modalities
PurposeAlthough a significant number of reports on new therapeutic options for refractory Kawasaki disease (KD) such as steroid, infliximab, or repeated intravenous immunoglobulin (IVIG) are available, their effectiveness in reducing the prevalence of coronary artery lesions (CAL) remains controvers...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Book |
| Published: |
Korean Pediatric Society,
2016-08-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|